| No. of studies | PD group | LR group | OR | 95%CI | p value | Heterogeneity (I2), % | Egger’s test (p value) | ||
---|---|---|---|---|---|---|---|---|---|---|
Total | Events | Total | Events | |||||||
Gender (male) | 9 | 173 | 102 | 345 | 173 | 1.38 | 0.95–2.02 | 0.09 | 0 | – |
Location(D2) | 8 | 128 | 83 | 292 | 110 | 3.39 | 1.69–6.79 | < 0.001 | 50 | – |
Mitotic count ≥5 | 7 | 148 | 55 | 288 | 60 | 2.24 | 1.42–3.52 | < 0.001 | 0 | – |
Risk category (High+Intermediate) | 9 | 173 | 106 | 345 | 119 | 3.17 | 2.13–4.71 | < 0.001 | 0 | – |
Margins resection (R1 + R2) | 10 | 184 | 3 | 402 | 28 | 0.54 | 0.20–1.45 | 0.22 | 0 | 0.181 |
Postoperative complication | 10 | 196 | 80 | 427 | 82 | 2.90 | 1.90–4.42 | < 0.001 | 10 | 0.319 |
Imatinib therapy | 5 | 84 | 26 | 176 | 38 | 1.78 | 0.93–3.38 | 0.08 | 0 | – |